Influenza vaccination in patients with end-stage renal disease

Bibliography

• Dalrymple LS, Go AS. Epidemiology of acute infections among patients with chronic kidney disease. Clin J Am Soc Nephrol 2008;3:1487–93
   PubMed Web of Science ®Google Scholar
• Naqvi SB, Collins AJ. Infectious complications in chronic kidney disease. Adv Chronic Kidney Dis 2006;13:199–204
   PubMed Web of Science ®Google Scholar
• Collins AJ, Yee J. Infectious complications in patients with chronic kidney disease. Adv Chronic Kidney Dis 2006;13:197–8
   PubMed Web of Science ®Google Scholar
• United States Renal Data System. The 2014 Annual Dara Report. Volume 2 End Stage Renal Disease in the United States. Chapter 3: Hospitalization. Available from: http://www.usrds.org/2014/view/v2_04.aspx Accessed on 27 March 2015]
   Google Scholar
• Aslam N, Bernardini J, Fried L, et al. Comparison of infectious complications between incident hemodialysis and peritoneal dialysis patients. Clin J Am Soc Nephrol 2006;1:1226–33
   PubMed Web of Science ®Google Scholar
• United States Renal Data System. The 2014 Annual Dara Report. Volume 2 End Stage Renal Disease in the United Chapter 5: Mortality. Available from: http://www.usrds.org/2014/view/v2_05.aspx [Accessed on 27 March 2015]
   Google Scholar
• Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001;120:1883–7
   PubMed Web of Science ®Google Scholar
• Sarnak MJ, Jaber BL. Mortality caused by sepsis in patients with end-stage renal disease compared with the general population. Kidney Int 2000;58:1758–64
   PubMed Web of Science ®Google Scholar
• Morens DM, Taubenberger JK, Harvey HA, Memoli MJ. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med 2010;38(4 Suppl):e10–20
   PubMedGoogle Scholar
• Molinari NA, Ortega-Sanchez IR, Messonnier ML, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007;25:5086–96
   PubMed Web of Science ®Google Scholar
• Antonova EN, Rycroft CE, Ambrose CS, et al. Burden of paediatric influenza in Western Europe: a systematic review. BMC Public Health 2012;12:968
   PubMed Web of Science ®Google Scholar
• Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ 2013;16:264–77
   PubMedGoogle Scholar
• Advisory Committee on Immunization Practice Recommended Adult Immunization Schedule—United States -. 2015. Available from: http://www.cdc.gov/vaccines/schedules/downloads/adult/adult-schedule.pdf [Accessed on 27 March 2015]
   Google Scholar
• Palache A, Tainijoki-Seyer J, Collins T. The link between seasonal influenza and NCDs: strategies for improving vaccination coverage. Health 2014;6:2724–35
   Google Scholar
• United States Renal Data System Chapter 3: Clinical Indicators and Preventive Care. Available from: www.usrds.org/2014/view/v2_03.aspx?zoom_highlight=influenza+vaccination [Accessed on 10 March 2014]
   Google Scholar
• Vaziri ND, Pahl MV, Crum A, Norris K. Effect of uremia on structure and function of immune system. J Ren Nutr 2012;22:149–56
   PubMed Web of Science ®Google Scholar
• Yoon JW, Pahl MV, Vaziri ND. Spontaneous leukocyte activation and oxygen-free radical generation in end-stage renal disease. Kidney Int 2007;71:167–72
   PubMed Web of Science ®Google Scholar
• Gollapudi P, Yoon JW, Gollapudi S, et al. Leukocyte toll-like receptor expression in end-stage kidney disease. Am J Nephrol 2010;31:247–54
   PubMed Web of Science ®Google Scholar
• Meier P, Golshayan D, Blanc E, et al. Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J Am Soc Nephrol 2009;20:1368–84
   PubMed Web of Science ®Google Scholar
• Hendrikx TK, van Gurp EA, Mol WM, et al. End-stage renal failure and regulatory activities of D4+CD25bright+FoxP3+ T-cells. Nephrol Dial Transplant 2009;24:1969–78
   PubMed Web of Science ®Google Scholar
• Vaziri ND. Oxidative stress in uremia: nature, mechanisms, and potential consequences. Semin Nephrol 2004;24:469–73
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Norris K. Lipid disorders and their relevance to outcomes in chronic kidney disease. Blood Purif 2011;31:189–96
   PubMed Web of Science ®Google Scholar
• Kaseda R, Jabs K, Hunley TE, et al. Dysfunctional high-density lipoproteins in children with chronic kidney disease. Metabolism 2015;64:263–73
   PubMed Web of Science ®Google Scholar
• Chonchol M. Neutrophil dysfunction and infection risk in end-stage renal disease. Semin Dial 2006;19:291–6
   PubMed Web of Science ®Google Scholar
• Agrawal S, Gollapudi P, Elahimehr R, et al. Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production. Nephrol Dial Transplant 2010;25:737–46
   PubMed Web of Science ®Google Scholar
• Lisowska KA, Debska-Slizie´n A, Jasiulewicz A, et al. Hemodialysis affects phenotype and proliferation of CD4-positive T lymphocytes. J Clin Immunol 2012;32:189–200
   PubMed Web of Science ®Google Scholar
• Libetta C, Rampino T, Dal Canton A. Polarization of T-helper lymphocytes toward the Th2 phenotype in uremic patients. Am J Kidney Dis 2011;38:286–95
   Google Scholar
• Kim KW, Chung BH, Jeon EJ, et al. B cell-associated immune profiles in patients with end-stage renal disease (ESRD). Exp Mol Med 2012;44:465–72
   PubMed Web of Science ®Google Scholar
• Kato S, Chmielewski M, Honda H, et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol 2008;3:1526–33
   PubMed Web of Science ®Google Scholar
• Paglialonga F, Esposito S, Edefonti A, Principi N. Catheter-related infections in children treated with hemodialysis. Pediatr Nephrol 2004;19:1324–33
   PubMed Web of Science ®Google Scholar
• Neuhaus TJ. Immunization in children with chronic renal failure: a practical approach. Pediatr Nephrol 2004;19:1334–9
   PubMed Web of Science ®Google Scholar
• Janus N, Vacher LV, Karie S, et al. Vaccination and chronic kidney disease. Nephrol Dial Transpl 2008;23:800–7
   PubMed Web of Science ®Google Scholar
• Neu AM, Warady BA, Lederman HM, et al. Hypogammaglobulinemia in infants and young children maintained on peritoneal dialysis. Perit Dial Int 1998;18:440–3
   PubMed Web of Science ®Google Scholar
• Schindowski K, Frohlich L, Maurer K, et al. Age-related impairment of human T lymphocytes’ activation: specific differences between CD4(+) and CD8(+) subsets. Mech Ageing Dev 2002;123:375–90
   PubMed Web of Science ®Google Scholar
• Adderson EE, Johnston JM, Shackerford PG, Carroll WL. Development of the human antibody repertoire. Pediatr Res 1992;32:257–63
   PubMed Web of Science ®Google Scholar
• Soni R, Horowitz B, Unruh M. Immunization in end-stage renal disease: opportunity to improve outcomes. Semin Dial 2013;26:416–26
   PubMed Web of Science ®Google Scholar
• Keane WR, Helderman JH, Luby J, et al. Epidemic renal transplant rejection associated with influenza A Victoria. Proc Clin Dial Transplant Forum 1978;8:232–6
   PubMedGoogle Scholar
• Gabriel R, Selwyn S, Brown D, et al. Virus infections and acute renal transplant rejection. Nephron 1976;16:282–6
   PubMedGoogle Scholar
• Briggs JD, Timbury MC, Paton AM, Bell PR. Viral infection and renal transplant rejection. BMJ 1972;4:520–2
   PubMed Web of Science ®Google Scholar
• Kumar D, Michaels MG, Morris MI, et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010;10:521–6
   PubMed Web of Science ®Google Scholar
• Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002;2:287–91
   PubMed Web of Science ®Google Scholar
• Camargo LF, de Sandes-Freitas TV, Silva CD, et al. Morbimortality of pandemic influenza A H1N1 infection in kidney transplant recipients requiring hospitalization: a comparative analysis with nonimmunocompromised patients. Transplantation 2012;93:69–72
   PubMed Web of Science ®Google Scholar
• Kunisaki KM, Janoff EN. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses. Lancet Infect Dis 2009;9:493–504
   PubMed Web of Science ®Google Scholar
• Marcelli D, Marelli C, Richards N. Influenza A(H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 2009;24:3566–72
   PubMed Web of Science ®Google Scholar
• Harriman K, Rosenberg J, Robinson S, et al. Novel influenza A (H1N1) virus infections among health-care personnel—United States, April–May 2009. MMWR 2009;58(23):641–5
   PubMedGoogle Scholar
• Kaufman MA, Duke GJ, McGain F, et al. Life-threatening respiratory failure from H1N1 influenza 09 (Human swine influenza eMJA Rapid online publication). 2009. Available from: http://www.mja.com.au/public/issues/191_03_030809/kau10748_fm.html [Accessed on 27 March 2015]
   Google Scholar
• Cappel R, Van Beers D, Liesnard C, Dratwa M. Impaired humoral and cell-mediated immune responses in dialyzed patients after influenza vaccination. Nephron 1983;33:21–5
   PubMed Web of Science ®Google Scholar
• Beyer WE, Versluis DJ, Kramer P, et al. Trivalent influenza vaccine in patients on haemodialysis: impaired seroresponse with differences for A-H3N2 and A-H1N1 vaccine components. Vaccine 1987;5:43–8
   PubMed Web of Science ®Google Scholar
• Rautenberg P, Teifke I, Schlegelberger T, Ullmann U. Influenza subtype-specific IgA, IgM and IgG responses in patients on hemodialysis after influenza vaccination. Infection 1988;16:323–8
   PubMed Web of Science ®Google Scholar
• Antonen JA, Hannula PA, Pyhala R, et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 2000;86:56–61
   PubMed Web of Science ®Google Scholar
• Dikow R, Eckerle I, Ksoll-Rudek D, et al. Immunogenicity and efficacy in hemodialysis patients of an AS03(A)-adjuvanted vaccine for 2009 pandemic influenza A(H1N1): a nonrandomized trial. Am J Kidney Dis 2011;57:716–23
   PubMed Web of Science ®Google Scholar
• Temiz G, Kasifoglu N, Kiris A, et al. Immune response after a single vaccination against 2009 influenza A H1N1 in hemodialysis patients. Ren Fail 2010;32:716–20
   PubMed Web of Science ®Google Scholar
• Labriola L, Hombrouck A, Marechal C, et al. Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients. Nephrol Dial Transplant 2011;26:1424–8
   PubMed Web of Science ®Google Scholar
• Broeders NE, Hombrouck A, Lemy A, et al. Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. Clin J Am Soc Nephrol 2011;6:2573–8
   PubMed Web of Science ®Google Scholar
• Crespo M, Collado S, Mir M, et al. Efficacy of influenza A H1N1/2009 vaccine in hemodialysis and kidney transplant patients. Clin J Am Soc Nephrol 2011;6:2208–14
   PubMed Web of Science ®Google Scholar
• Beaudreuil S, Krivine A, Hebibi H, et al. Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patients. Hum Vaccin 2011;7:868–73
   PubMed Web of Science ®Google Scholar
• Chang YT, Guo CY, Tsai MS, et al. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder. hemodialysis patients. Vaccine 2012;30:5009–18
   PubMed Web of Science ®Google Scholar
• Son J, Lee SB, Lee DW, et al. Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients. Clin Exp Nephrol 2013;17:275–83
   PubMed Web of Science ®Google Scholar
• Azak A, Huddam B, Kocak G, et al. Antibody response after single H1N1 influenza vaccine in chronic dialysis patients. Ther Apher Dial 2013;17:55–99
   PubMed Web of Science ®Google Scholar
• Moon SJ, Lee SH, Byun YH, et al. Risk factors affecting seroconversion after influenza A/H1N1 vaccination in hemodialysis patients. BMC Nephrol 2012;13:165
   PubMed Web of Science ®Google Scholar
• Esposito S, Montinaro V, Groppali E, et al. Live attenuated intranasal influenza vaccine. Hum Vaccin Immunother 2012;8:76–80
   PubMed Web of Science ®Google Scholar
• Jordan MC, Rousseau WE, Tegtmeier GE, et al. Immunogenicity of inactivated influenza virus vaccine in chronic renal failure. Ann Intern Med 1973;79:790–4
   PubMed Web of Science ®Google Scholar
• Hodges GR, Davis JW, Lewis HJr, et al. Response to influenza A vaccine among high-risk patients. South Med J 1979;72:29–32
   PubMed Web of Science ®Google Scholar
• Osanloo EO, Berlin BS, Popli S, et al. Antibody responses to influenza vaccination in patients with chronic renal failure. Kidney Int 1978;14:614–18
   PubMed Web of Science ®Google Scholar
• Ortbals DW, Marks ES, Liebhaber H. Influenza immunization in patients with chronic renal disease. JAMA 1078;239:2562–5
   Google Scholar
• Song JY, Cheong HJ, Ha SH, et al. Active influenza immunization in hemodialysis patients: comparison between single-dose and booster vaccination. Am J Nephrol 2006;26:206–11
   PubMed Web of Science ®Google Scholar
• Scharpé J, Peetermans WE, Vanwalleghem J, et al. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 2009;54:77–85
   PubMed Web of Science ®Google Scholar
• Vogtländer NP, Brown A, Valentijn RM, et al. Impaired response rates, but satisfying protection rates to influenza vaccination in dialysis patients. Vaccine 2004;22:2199–201
   PubMed Web of Science ®Google Scholar
• Ott U, Sauerbrei A, Lange J, et al. Serological response to influenza A H1N1 vaccine (Pandemrix) and seasonal influenza vaccine 2009/2010 in renal transplant recipients and in hemodialysis patients. Med Microbiol Immunol 2012;201:297–302
   PubMed Web of Science ®Google Scholar
• Lertdumrongluk P, Changsirikulchai S, Limkunakul C, et al. Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients. Vaccine 2012;30:1108–14
   Google Scholar
• Gavaldà J, Cabral E, Perez-Romero P, et al. Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients. Pediatr Transplant 2013;17:403–6
   PubMed Web of Science ®Google Scholar
• Donmez O, Akaci O, Albayrak N, Altas A. Safety and effectiveness of a 2009 H1N1 vaccine in chronic kidney disease children. Nephron Clin Pract 2014;128:341–4
   PubMedGoogle Scholar
• Kelen K, Ferenczi D, Jankovics I, et al. H1N1 vaccination in pediatric renal transplant patients. Transplant Proc 2011;43:1244–6
   PubMed Web of Science ®Google Scholar
• Esposito S, Tagliaferri L, Daleno C, et al. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Vaccine 2011;29:1677–82
   PubMed Web of Science ®Google Scholar
• Principi N, Esposito S. Adjuvanted influenza vaccines. Hum Vaccin Immunother 2012;8:59–66
   PubMed Web of Science ®Google Scholar
• Rautenberg P, Proppe D, Schütte A, Ullmann U. Influenza subtype-specific immunoglobulin A and G responses after booster versus one double-dose vaccination in hemodialysis patients. Eur J Clin Microbiol Infect Dis 1989;8:897–900
   PubMed Web of Science ®Google Scholar
• Tanzi E, Amendola A, Pariani E, et al. Lack of effect of a booster dose of influenza vaccine in hemodialysis patients. J Med Virol 2007;79:1176–9
   PubMed Web of Science ®Google Scholar
• Versluis DJ, Beyer WE, Masurel N, Weimar W. Influenza vaccination in dialysis and transplant patients. Antiviral Res 1985(Suppl 1):289–92
   PubMedGoogle Scholar
• Vogtlander NPJ, Brown A, Versluis DJ, Beyer WE. Intact humoral immune response in patients on continuous ambulatory peritoneal dialysis. Nephron 1988;49:16–19
   PubMedGoogle Scholar
• Remschmidt C, Wichmann O, Harder T. Influenza vaccination in patients with end-stage renal disease: systematic review and assessment of quality of evidence related to vaccine efficacy, effectiveness, and safety. BMC Med 2014;12:244
   PubMed Web of Science ®Google Scholar
• McGrath LJ, Kshirsagar AV, Cole SR, et al. Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med 2012;172:548–54
   PubMed Web of Science ®Google Scholar
• Gilbertson DT, Unruh M, McBean AM, et al. Influenza vaccine delivery and effectiveness in end-stage renal disease. Kidney Int 2003;63:738–43
   PubMed Web of Science ®Google Scholar
• Wang IK, Lin CL, Lin PC, et al. Effectiveness of influenza vaccination in patients with end-stage renal disease receiving hemodialysis: a population-based study. PLoS ONE 2013;8:e58317
   PubMed Web of Science ®Google Scholar
• Bond TC, Spaulding AC, Krisher J, McClellan W. Mortality of dialysis patients according to influenza and pneumococcal vaccination status. Am J Kidney Dis 2012;60:959–65
   PubMed Web of Science ®Google Scholar
• Slinin Y, Foley RN, Collins AJ. Clinical epidemiology of pneumonia in hemodialysis patients: the USRDS waves 1, 3, and 4 study. Kidney Int 2006;70:1135–41
   PubMed Web of Science ®Google Scholar
• Nikoskelainen J, Vaananen P, Forsstrom J, Kasanen A. Influenza vaccination in patients with chronic renal failure. Scand J Infect Dis 1982;14:245–51
   PubMed Web of Science ®Google Scholar
• Cavdar C, Sayan M, Sifil A, et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients and children. Scand J Urol Nephrol 2003;37:71–6
   PubMed Web of Science ®Google Scholar
• Evison J, Farese S, Seitz M, et al. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 2009;48:1402–12
   PubMed Web of Science ®Google Scholar
• Fernández-Ruiz M, Lumbreras C, Arrazola MP, et al. Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients. Transpl Infect Dis 2015;17(2):314–21
   PubMed Web of Science ®Google Scholar
• Esposito S, Mastrolia MV, Ghio L, et al. Influenza immunization in hemodialyzed or kidney transplanted adolescents and young adults. Expert Rev Vaccines 2014;13:1059–66
   PubMed Web of Science ®Google Scholar
• Esposito S, Mastrolia MV, Prada E, et al. Vaccine administration in children with chronic kidney disease. Vaccine 2014;32:6601–6
   PubMed Web of Science ®Google Scholar
• Printza N, Farmaki E, Bosdou J, et al. Pandemic influenza A 2009 (H1N1) vaccination in high risk children with chronic renal diseases: acceptance and perceptions. Hum Vaccin 2010;6:819–22
   PubMed Web of Science ®Google Scholar